SELECT LANGUAGE BELOW

RFK Jr. Declares a Total Overhaul of CDC Vaccine Advisors

RFK Jr. Declares a Total Overhaul of CDC Vaccine Advisors

HHS Director Announces Major Changes in Vaccination Committee

Robert F. Kennedy Jr., the Director of Health and Human Services (HHS), revealed on Monday that a “clean sweep” has taken place regarding the advisory committee overseeing children’s vaccination schedules.

According to an HHS statement, all 17 current members of the committee have been dismissed.

“Our goal today is to rebuild public trust rather than just cater to pro-vaccine or anti-vaccine narratives,” Kennedy remarked. “The public should be aware that bias exists, but we are committed to transparency and addressing conflicts of interest.”

The Advisory Committee on Immunization Practices (ACIP), made up of external scientists, evaluates epidemiological research, balances the benefits and potential side effects observed in clinical trials, and provides recommendations for daily vaccination schedules for both children and adults. Their meetings are open to the public.

ACIP’s recommendations can clarify which vaccinations will be covered by health plans.

During the Covid-19 pandemic, ACIP became a focal point for controversy, raising questions about potential payments received by advisers from pharmaceutical companies. In response, HHS launched a new tool in March permitting users to look up possible conflicts of interest tied to these advisers.

This recent press release, however, brings attention to concerns regarding the entire ACIP formed under the Biden administration. Without this overhaul, the committee would have predominantly featured appointments from the Trump era until 2028, as stated by HHS.

Members of ACIP are appointed by the HHS Secretary and can serve for a maximum of four years, as outlined by the Kaiser Family Foundation.

The next ACIP meeting is set for June 25 to June 27. It’s uncertain whether they will address the recent Food and Drug Administration framework, which suggests that new clinical trials may be needed for Covid-19 booster shots, especially for those without underlying health issues who might be at risk for severe illness.

Facebook
Twitter
LinkedIn
Reddit
Telegram
WhatsApp

Related News